A new revision of the EU GMP Annex 1 was released by the European Commission in August of 2022. This long-awaited revision replaces that released in 2008 and comes two years after the release of the most recent draft version of the document.
A Pfizer case study published in July 2018 by José-Miguel Montenegro-Alvarado, et. al. highlights the benefits provided by rapid microbial methods in evaluating risks and expediting recovery after a hurricane.
MicronView Limited takes advantage of optics and biotechnology to achieve fast, real-time sterile environment monitoring, by providing advanced monitoring instruments and consumable for production environments and finished products of food, pharmaceutical and cosmetic industries.